ConductScience.org, home

Trial · NCT07895472

Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee

NCT07895472, Not applicable, Not yet recruiting, McMaster University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee. Trials, record NCT07895472. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895472

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee
NCT number
NCT07895472
Status
Not yet recruiting
Phases
Not applicable
Enrollment
170 participants, estimated
Lead sponsor
McMaster University
Conditions
Knee Arthroplasty, Total, Partial Knee Arthroplasty, Chronic Pain, Postoperative, Osteoarthritis (OA) of the Knee
Interventions
Standard care, Multicomponent opioid reduction and pain management pathway
First posted
2026-10-26
Last updated
2026-10-30

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChronic postsurgical pain3 months after surgery
Presence of chronic postsurgical pain (binary) is defined per the definition adopted in International Classification of Diseases version 11; pain develops or increases in intensity after a surgical procedure or a tissue injury, pain persists beyond the healing process (3 months), present either at the surgical/area, or projected onto the innervation area of a nerve, other causes of pain (e.g. pre-existing pain conditions, infection, malignancy) are excluded .
SecondaryModerate-to-severe chronic postsurgical pain3, 6, 9, and 12 months after surgery
Presence of chronic postsurgical pain (binary) is defined as per the definition adopted in International Classification of Diseases version 11; mild-to-moderate is defined as pain intensity of ≥4/10 during ambulation over the last week. Pain intensity will be measured on a numeric rating scale of 0-10 where a lower score is better.
SecondaryPain controlUp to 3 months after surgery
Time to achieve good pain control (time-to-event); good pain control will be defined as achieving a state of pain intensity of \<4/10 during ambulation over the past week without the need for daily opioid medication for the operated knee. Pain intensity will be measured on a numeric rating scale of 0-10 where a lower score is better.
SecondaryChronic postsurgical pain6, 9, and 12 months after surgery
Presence of chronic postsurgical pain (Binary) is defined per the definition adopted in International Classification of Diseases version 11; pain develops or increases in intensity after a surgical procedure or a tissue injury, pain persists beyond the healing process (3 months), present either at the surgical/area, or projected onto the innervation area of a nerve, other causes of pain (e.g. pre-existing pain conditions, infection, malignancy) are excluded.
SecondaryPersistent opioid use3, 6, 9, and 12 months after surgeryPresence of persistent opioid use (binary), based on patient reporting indicating the need for daily opioid use that started after surgery or increased after surgery .
SecondaryChronic postsurgical pain intensity3, 6, 9, and 12 months after surgeryAverage intensity of chronic postsurgical pain (continuous) at rest and with movement. Pain intensity will be measured on a numeric rating scale of 0-10 where 0 is better.
SecondarySatisfaction with pain control3, 6, 9, and 12 months after surgerySatisfaction with pain control (continuous) will be measured using a 0 to 100 scale where a higher score is better satisfaction.
SecondaryKnee function3, 6, 9, and 12 months after surgeryUsing the 12-item Oxford Knee Score (continuous) to assess knee function and pain following a total knee replacement. The score range is 0-48 where a higher score is better function.
SecondaryQuality of life3, 6, 9, and 12 months after surgery
Measured using Euro-Qol 5 dimensions scale consisting of 5 dimensions, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. This will be transformed to a utility score where 0 is death and 1 is full health (continuous).
OtherAdverse eventsFrom baseline to 12 months after surgeryOperative and knee-related complications, pain medication related adverse events, readmissions, and all serious adverse events

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07895472

GET https://conductscience.org/api/trials/v1/NCT07895472/registered